As part of our COVID-19 Impact Series, we have been exploring potential impacts to our nationwide network of health system specialty pharmacies. Read More >

News

Discover the latest articles and industry news about health system specialty pharmacy, Excelera and the Excelera Network.

Pharmacy Times / Directions in Oncology

Oral Therapies for Hormone Receptor – Positive Breast Cancers

Amanda Manoogian, PharmD, BCOP, Clinical Pharmacy Coordinator Specialty Pharmacy, Clinical Services, Partners Healthcare

Hormone receptor-positive (HR-positive) breast cancer is the most common subtype of invasive breast cancer. Treatment has been focused on targeting the estrogen receptor pathway, and endocrine therapy (ET) has remained the mainstay treatment for these patients.

Read article
KIVI TV - Boise

Improving care for cystic fibrosis patients with pharmacy program

For people living with cystic fibrosis, St. Luke’s is making it easier to keep up, by putting a pharmacy directly in the clinic. A new grant from the Cystic Fibrosis Foundation goes towards implementing a pharmacy program for the center in Boise.

Read article
St. Luke's Blog

Kid care takes center stage at St. Luke’s

Children are a big deal at St. Luke’s. The $42 million, 100,000-square foot Idaho Elks Children’s Pavilion, which opened this summer in Boise, makes that very clear. But caring for children goes beyond the Children’s Pavilion and extends across the St. Luke’s Health System.

Read article
Minneapolis / St. Paul Business Journal

Excelera launching pharmacy benefit management solution, seeking $6 million

ExceleraRx Corp., a company that creates a network of health systems to drive access to expensive specialty drugs, has raised $2 million of a planned $6 million round.

Read article
Monument Health Press Release

Regional Health Will Become Monument Health

Regional Health today announced it will become Monument Health in January 2020. It will continue to employ more than 4,500 physicians and caregivers in 20 Western South Dakota and Eastern Wyoming communities after the name change.

Read article
Patient Care Online

Improving CF Medication Adherence: A Specialty Pharmacy at Work – Part 1

Patient Care (PC) recently spoke with Sandy ILL, PharmD, CSP, a specialty pharmacist; Kim Ehlert, PharmD, a clinical pharmacist; and Tim Affeldt, PharmD, vice president of specialty pharmacy at Fairview Health Services, a nonprofit, integrated health system based in Minneapolis, Minn, to discuss how they address CF medication adherence in their health system.

Read article
Patient Care Online

Working with Barriers to CF Treatment Adherence, the Fairview Way – Part 2

According to the latest guidelines for cystic fibrosis (CF) published in U.S. Pharmacist, pharmacists are an important part of counseling patients with CF. The Fairview CF medication adherence rate is 70% higher than among patients at retail pharmacies.

Read article
SPS Commerce Blog

TCSW19 recap and the importance of business culture: Insights from Minnesota CEOs

Twin Cities Startup Week (TCSW) is always a busy and inspiring week for entrepreneurs and business professionals across the region. SPS Commerce was a sponsor of the 2019 event, and also hosted an executive panel at SPS Tower in Minneapolis.

Read article
Patient Engagement HIT

Industry Collaboration Drives Managed Care in Specialty Pharmacy

The role of the specialty pharmacy is evolving and growing, and as more health systems integrate these entities into their facilities, industry collaboration will be key to for understanding the level of managed care needed for complex patients.

Read article
Pharmacy Times

Takeaways from NASP: The State of Pricing Reform Efforts and AI Decision Support in Specialty Pharmacy

Michael Carter, Corporate Director of Specialty Pharmacy, President and CEO Partners HealthCare SP, Inc

The National Association of Specialty Pharmacy (NASP) held its 7th Annual Meeting and Expo in September as experts throughout the industry discussed the rapid developments in specialty pharmacy, including national legislative and regulatory policy, and shared the latest on innovations that will improve care for complex patients.

Read article


LinkedIn icon